Guest Editor(s)

• Prof. Shinji Tanaka

  Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.

  Website | E-mail

Special Issue Introduction

Endoscopic submucosal dissection (ESD) in the treatment of digestive tract tumors has become easier and safer, which, then, has been standardized gradually all over the word in relation to the progress of endoscopy and the equipment. There are various knives for ESD with each characteristic. Besides, new injection solution, counter traction device, distal attachment, suturing device, special endoscope, technical strategy, etc. have been reported.

Furthermore, the indication of ESD for digestive tract tumors has been expanded based on the new knowledge in relation to the curative histologic conditions for ESD resected specimens using many accumulated cases until now. ESD for digestive tract tumors is considered to be not only a therapeutic resection method but total excisional biopsy. Basically, benign tumor is allowed to be resected in piecemeal manner. However, cancerous lesion should be resected en bloc with tumor-free margin to obtain the precise histologic findings for determining curability. In this aspect, ESD is an effective and suitable therapeutic method in the treatment of digestive tract tumors.

In this special issue, we will introduce both indication of ESD and curative condition after ESD. Following that, we will also introduce recent innovative ESD technologies for whole digestive tract tumors from larynx to rectum.

Participants

Dr. Yuji Urabe, from Hiroshima University, Hiroshima, Japan.
Dr. Ryu Ishihara, from Osaka National Cancer Center, Osaka, Japan.
Dr. Haruhiro Inoue, from Showa University, Koto Toyosu Hospital, Japan.
Dr. Ken-ichi Goda, from Fukushima Medical University, Fukiushima, Japan.
Dr. Tsuneo Oyama, from Saku General Hospital, Saku, Japan.
Dr. Takuji Gotoda, from Nippon University, Tokyo, Japan.
Dr. Chika Kusano, from Nippon University, Tokyo, Japan.
Dr. Noriya Uedo, from Osaka National Cancer Center, Osaka, Japan.
Dr. Hiroyuki Ono, from Shizuoka Cancer Center, Santogun, Japan.
Dr. Naohisa Yahagi, from Keio University, Tokyo, Japan.
Dr. Kohei Takizawa, from Sapporo Kinentou Hospital, Hokkaido, Japan.
Dr. Shiro Oka, from Hiroshima University, Hiroshima, Japan.
Dr. Yoji Takeuchi, from Osaka National Cancer Center, Osaka, Japan.
Dr. Satoki Shichijo, from Osaka National Cancer Center, Osaka, Japan.
Dr. Hironori Yamamoto, from Jichi Medical University, Shimono, Japan.
Dr. Yutaka Saito, from National Cancer Center Hospita, Tokyo, Japan.
Dr. Toshio Uraoka, from Gunma University, Mabashi, Japan.
Dr. Toshio Kuwai, from Kure National Hospital, Kure, Japan.
Dr. Takashi Toyonaga, from Kobe University, Kobe, Japan.
The list is arranged in no particular order and to be updated.

Submission Deadline

31 Oct 2021

Submission Information

For Author Instructions, please refer to http://misjournal.net/pages/view/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=mis&SpecialIssueId=682
Submission Deadline: 31 Oct 2021
Contacts: Lillian Lee, Assistant Editor, lillian@misjournal.net